Different fibrovascularization rate between coralline hydroxyapatite and high density porous polyethylene (medpore) measured by 99mtc-mdp bone scintigraphy 6 months after intraorbital implantation

Nuclear Medicine Communications

Volumn 24, Issue 12, 2003, Pages 1237-1241

  Pan, M H ^a   WU, Y W ^a   Yen, R F ^a   Tzen, K Y ^a   Liao, S L ^a   Kao, C H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

99mTc bone scan; Coralline hydroxyapatite; High density porous polyethylene (Medpore)

Indexed keywords

HYDROXYAPATITE; MEDRONATE TECHNETIUM TC 99M; POLYETHYLENE; ROSEOLIC ACID; BIOMATERIAL; CORALLINE HYDROXYAPATITE; DIAGNOSTIC AGENT; MEDPOR; POLYETHYLENE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BONE DENSITY; BONE SCINTISCANNING; CELL GROWTH; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FIBROBLAST; HUMAN; IMPLANTATION; POROSITY; STATISTICAL SIGNIFICANCE; VASCULARIZATION; ADOLESCENT; ADULT; AGED; ANGIOGENESIS; CERAMICS; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EQUIPMENT; FEMALE; FOREIGN BODY; MALE; MATERIALS TESTING; METHODOLOGY; MIDDLE AGED; ORBIT IMPLANT; PRESCHOOL CHILD; SCINTISCANNING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOCOMPATIBLE MATERIALS; CERAMICS; CHILD; CHILD, PRESCHOOL; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOREIGN BODIES; HUMANS; HYDROXYAPATITES; MALE; MATERIALS TESTING; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; ORBITAL IMPLANTS; POLYETHYLENES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE; TREATMENT OUTCOME;

EID: 4344624080     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200312000-00006     Document Type: Article

References (9)

1. Civelek AC, Pacheco EM, Natarajan TK, Wagner HN, Iliff NT. Quantitative measurement of vascularization and vascular ingrowth rate of coralline hydroxyapatite ocular implant by Tc-99m MDP bone scan. Clin Nucl Med 1995; 20: 779-787.
2. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991; 98: 370-371.
3. Shields CL, Shields JA, Eagle RC, De Potter P. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol 1991; 111: 363-366.
4. Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994; 78: 702-706.
5. Karesh JW, Dresner SC. High-density porous polyethylene (Medpore) as a successful anophthalmic socket implant. Ophthalmology 1994; 101: 1688-1696.
6. Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Surv Ophthalmol 2000; 44: 277-301.
7. Ferrone PJ, Dutton JJ. Rate of vascularization of coralline hydroxyapatite ocular implants. Ophthalmology 1992; 99: 376-379.
8. Pacheco E, Civelek AC, Natarajan TK, D'Anna SA, Iliff NT, Green W. Clinicopathological correlation of technetium bone scan in vascularization of hydroxyapatite implants: a primate model. Arch Ophthalmol 1997; 115: 1173-1177.
9. Kenney EB, Lekovic V, S Ferreira JC, Han T, Dimitrijevic B, Carranza Jr FA. Bone formation within porous Hydroxyapatite implants in human periodontal defects. J Periodontol 1986; 57: 76-83.